The DOI matches its Crossref record.
A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant
Abstract
A phase I randomized, double-blind, placebo-controlled trial was done with a cytomegalovirus (CMV) vaccine based on the envelope glycoprotein, gB, combined with a novel adjuvant, MF59. Participants received CMV gB vaccine with MF59 or CMV gB with alum or placebo at 0, 1, and 6 months. A fourth vaccine was given at 12 months to a subgroup. Levels of neutralizing antibody and antibody to gB 2 weeks after the third dose of vaccine exceeded those in seropositive control subjects. the formulation with MF59 was more immunogenic than that with alum. The optimal dose of gB appeared to be between 5 and 30 microg. The fourth dose produced a prompt rise in antibody level. There were no serious adverse events associated with vaccine. Local and systemic reactions were generally mild and, except for pain at the injection site, occurred with similar frequency in recipients of placebo and CMV vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kotton, C. N., Kumar, D., Caliendo, A. M., Huprikar, S., Chou, S., Danziger-Isakov, L., & Humar, A. (2018) · Transplantation · doi:10.1097/tp.0000000000002191 · Cited by 1,152
The “Silent” Global Burden of Congenital Cytomegalovirus
Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B., & Gupta, R. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00062-12 · Cited by 1,028
Self-citationKotton, C. N., Kumar, D., Caliendo, A. M., Åsberg, A., Chou, S., Snydman, D. R., Allen, U., & Humar, A. (2010) · Transplantation · doi:10.1097/tp.0b013e3181cee42f · Cited by 965
Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection
Nigro, G., Adler, S. P., La Torre, R., & Best, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043337 · Cited by 784
Kotton, C. N., Kumar, D., Caliendo, A. M., Åsberg, A., Chou, S., Danziger-Isakov, L., & Humar, A. (2013) · Transplantation · doi:10.1097/tp.0b013e31829df29d · Cited by 758
Vaccine Prevention of Maternal Cytomegalovirus Infection
Pass, R. F., Zhang, C., Evans, A., Simpson, T., Andrews, W., Huang, M.-L., Corey, L., Hill, J., Davis, E., Flanigan, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804749 · Cited by 713
Self-citationImmunobiology of Human Cytomegalovirus: from Bench to Bedside
Crough, T., & Khanna, R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-08 · Cited by 644
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Revello, M. G., & Gerna, G. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.680-715.2002 · Cited by 618
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Gandhi, M. K., & Khanna, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01202-2 · Cited by 563
Cheeran, M. C.-J., Lokensgard, J. R., & Schleiss, M. R. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-08 · Cited by 516
Griffiths, P. D., Stanton, A., McCarrell, E., Smith, C., Osman, M., Harber, M., Davenport, A., Jones, G., Wheeler, D. C., O'Beirne, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60136-0 · Cited by 389
Landolfo, S., Gariglio, M., Gribaudo, G., & Lembo, D. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00034-2 · Cited by 358
Halary, F., Amara, A., Lortat-Jacob, H., Messerle, M., Delaunay, T., Houlès, C., Fieschi, F., Arenzana-Seisdedos, F., Moreau, J.-F., & Déchanet-Merville, J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00447-8 · Cited by 356
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Modlin, J. F., Arvin, A. M., Fast, P., Myers, M., Plotkin, S., & Rabinovich, R. (2004) · Clinical Infectious Diseases · doi:10.1086/421999 · Cited by 331
Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research
Koelle, D. M., & Corey, L. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.96-113.2003 · Cited by 263
John, S., Yuzhakov, O., Woods, A., Deterling, J., Hassett, K., Shaw, C. A., & Ciaramella, G. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.029 · Cited by 229
Bernstein, D. I., Reap, E. A., Katen, K., Watson, A., Smith, K., Norberg, P., Olmsted, R. A., Hoeper, A., Morris, J., Negri, S., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.135 · Cited by 212
The history of vaccination against cytomegalovirus
Plotkin, S. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0388-z · Cited by 71
Perinatal Cytomegalovirus and Varicella Zoster Virus Infections
Bialas, K. M., Swamy, G. K., & Permar, S. R. (2015) · Clinics in Perinatology · doi:10.1016/j.clp.2014.10.006 · Cited by 54
Metadata
- Authors
- Pass, R. F., Duliegè, A., Boppana, S., Sekulovich, R., Percell, S., Britt, W., & Burke, R. L.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-10
- Volume
- 180
- Issue
- 4
- Pages
- 970-975
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2166789299
- Cited by
- 249
- References
- 0
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.